BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 35418526)

  • 1. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.
    Naruse M; Katabami T; Shibata H; Sone M; Takahashi K; Tanabe A; Izawa S; Ichijo T; Otsuki M; Omura M; Ogawa Y; Oki Y; Kurihara I; Kobayashi H; Sakamoto R; Satoh F; Takeda Y; Tanaka T; Tamura K; Tsuiki M; Hashimoto S; Hasegawa T; Yoshimoto T; Yoneda T; Yamamoto K; Rakugi H; Wada N; Saiki A; Ohno Y; Haze T
    Endocr J; 2022 Apr; 69(4):327-359. PubMed ID: 35418526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
    Funder JW; Carey RM; Mantero F; Murad MH; Reincke M; Shibata H; Stowasser M; Young WF
    J Clin Endocrinol Metab; 2016 May; 101(5):1889-916. PubMed ID: 26934393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of primary aldosteronism.
    Vilela LAP; Almeida MQ
    Arch Endocrinol Metab; 2017; 61(3):305-312. PubMed ID: 28699986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited.
    Williams TA; Reincke M
    Eur J Endocrinol; 2018 Jul; 179(1):R19-R29. PubMed ID: 29674485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.
    Nishikawa T; Omura M; Satoh F; Shibata H; Takahashi K; Tamura N; Tanabe A;
    Endocr J; 2011; 58(9):711-21. PubMed ID: 21828936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
    Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
    PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal Venous Sampling in Patients With Positive Screening but Negative Confirmatory Testing for Primary Aldosteronism.
    Umakoshi H; Naruse M; Wada N; Ichijo T; Kamemura K; Matsuda Y; Fujii Y; Kai T; Fukuoka T; Sakamoto R; Ogo A; Suzuki T; Nanba K; Tsuiki M;
    Hypertension; 2016 May; 67(5):1014-9. PubMed ID: 26975712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in the diagnosis and treatment of primary aldosteronism.
    Yoshida Y; Shibata H
    Hypertens Res; 2023 Jul; 46(7):1738-1744. PubMed ID: 37198444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of primary aldosteronism: an updated review.
    Chao CT; Wu VC; Kuo CC; Lin YH; Chang CC; Chueh SJ; Wu KD; Pimenta E; Stowasser M
    Ann Med; 2013 Jun; 45(4):375-83. PubMed ID: 23701121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a change to a novel chemiluminescent immunoassay for measuring plasma aldosterone on the diagnosis of primary aldosteronism.
    Kobayashi H; Nakamura Y; Abe M; Tanabe A; Sone M; Katabami T; Kurihara I; Ichijo T; Tsuiki M; Izawa S; Wada N; Yoneda T; Takahashi K; Tamura K; Ogawa Y; Inagaki N; Yamamoto K; Rakugi H; Naruse M;
    Endocr J; 2023 May; 70(5):489-500. PubMed ID: 36792218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary aldosteronism: The Mayo Clinic approach].
    Young W; Ladygina DO; Balutina OV; Beltsevich DG
    Ter Arkh; 2020 Nov; 92(10):83-87. PubMed ID: 33346484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism.
    Ohno Y; Sone M; Inagaki N; Kawashima A; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Ichijo T; Katabami T; Wada N; Sakamoto R; Ogawa Y; Yoshimoto T; Yamada T; Kawashima J; Matsuda Y; Kobayashi H; Kamemura K; Yamamoto K; Otsuki M; Okamura S; Izawa S; Okamoto R; Tamura K; Tanabe A; Naruse M;
    Hypertension; 2020 Jun; 75(6):1475-1482. PubMed ID: 32248705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.
    Funder JW; Carey RM; Fardella C; Gomez-Sanchez CE; Mantero F; Stowasser M; Young WF; Montori VM;
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3266-81. PubMed ID: 18552288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
    Weiner ID
    Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
    Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling.
    Nagasawa M; Yamamoto K; Rakugi H; Takeda M; Akasaka H; Umakoshi H; Tsuiki M; Takeda Y; Kurihara I; Itoh H; Ichijo T; Katabami T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Ogo A; Okamura S; Miyauchi S; Yanase T; Suzuki T; Kawamura T; Naruse M;
    J Hypertens; 2019 Jul; 37(7):1493-1499. PubMed ID: 31033727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of confirmatory tests in the diagnosis of primary aldosteronism.
    Huang CW; Tu KH; Fan KC; Tsai CH; Wang WT; Wang SY; Wu CY; Hu YH; Huang SH; Liu HW; Tseng FY; Wu WC; Chang CC; Lin YH; Wu VC; Hwu CM
    J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S104-S113. PubMed ID: 37173227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.